ZACKERY JOHNSON: Open Payments
NPI 1336767748 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 39 payments from 7 companies in 2025. Trend: 2023 $38 · 2024 $93 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $190 |
| Lundbeck LLC | 8 | $169 |
| Valinor Pharma, LLC | 5 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| PFIZER INC. | 2 | $29 |
| Abbott Laboratories | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: VYEPTI, QULIPTA, MOVANTIK, RELISTOR, UBRELVY, NURTEC ODT, ETERNA, Symbravo.
Industry payments across MS — which companies pay providers there.
